The peptide
Palmitoyl Tripeptide-38: Comprehensive Dermal Matrix Repair for Smoother Skin
Palmitoyl Tripeptide-38 is an innovative lipopeptide, synthesized by conjugating the matrikine-mimetic tripeptide KMK with palmitic acid, a modification that enables superior stratum corneum penetration. In cosmetic science, it is expertly positioned as a comprehensive structural repair active, stimulating the synthesis of six pivotal dermal matrix components: collagen I, II, and IV, fibronectin, hyaluronic acid, and laminin-5. Its sophisticated mechanism involves mimicking naturally occurring extracellular matrix degradation products, effectively signaling fibroblasts to rebuild the dermal–epidermal junction and visibly smooth deep expression lines from the inside out.
Market context: The peptide is predominantly recognized under the proprietary trade name Matrixyl™ synthe'6™ by Sederma, positioned as an advanced "matrix specialist" compared to older, exclusively collagen-focused peptides. Competitor marketing heavily leverages its multi-pathway targeting—collagen, fibronectin, and hyaluronic acid—to justify premium retail pricing in clinical-grade anti-aging serums for mature skin. Formulate Labs supplies Palmitoyl Tripeptide-38 only, a pure INCI blend, and does not sell or represent Matrixyl™ synthe'6™ or other supplier-branded actives.
Formulate Labs offers Palmitoyl Tripeptide-38 as a high-purity INCI blend suspended in a carrier system of Hydroxypropyl Cyclodextrin, Glycerin, and Water. This optimized suspension is designed for ease of incorporation into a variety of cosmetic formulations, typically recommended for use at 2.0% to 4.0%. Our commitment is to supply the pure active ingredient, ensuring formulators receive a consistent, quality material for their innovative product development.
We supply it at 0.03% standard or 0.3% lab concentrate in glycerin or Sea Kelp Bioferment carriers.
500
g/mol molecular weight (approx.)
2012
commercialised as Matrixyl synthe’6 (Sederma)
2
carrier options on this page